A fully digital and smart workplace offers many benefits: lower costs, improved quality, and higher productivity. Nearly everyone agrees about that. Yet in pharmaceutical manufacturing, the pace of change has been slow. Most companies still use at least some paper-based systems to guide and document processes. These entrenched and validated systems limit productivity and agility.
Want more ways to ensure compliance with user data authentication? Or more confidence in the Nymi approach? If so, our news is good news. So far, 2018 has been an incredibly exciting year for Nymi, from winning awards and entering new strategic partnerships to launching our latest authentication solution, Nymi Enterprise Edition™.
Nymi Enterprise Edition
This three-part blog series revisits an age-old topic through the lens of the latest technology. Starting with a brief introduction to the history of Title 21 CFR Part 11, we’ll take you through the industry changes that enable better data reliability and significant performance improvements over the traditional use of electronic signatures.
Part 1: History